Doctor profile · Federal record
Dr. Myles Jerdan, Medical Doctor
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Dermatology Physician · Dermatopathology Physician · Lagrange, GA
- NPI 1770549701
- Accepts Medicare
- MIPS 92.4 / 100 · 2023
- 47 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1605 Whitesville St
Lagrange, GA 302405903
(877) 231-3376
fax (850) 522-8354 - Mailing address
-
2505 Harrison Ave
Panama City, FL 324054464
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- August 28, 2020
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (4)
- Georgia #30796 · Tennessee #60136 · Georgia #D30796 · Georgia #030796
- Medicaid
- TN #Q053605
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770549701. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,369
Distinct HCPCS
10
Medicare allowed
$530,611
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 960 | 150 | $6 | |
G6001 |
Ultrasonic guidance for placement of radiation therapy fields | 636 | 33 | $163 | |
77280 |
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 589 | 32 | $243 | |
77401 |
Superficial and/or low voltage radiation treatment delivery | 587 | 30 | $37 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 492 | 282 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 308 | 207 | $41 | |
11102 |
Biopsy of related skin growth, first growth | 246 | 200 | $77 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 207 | 156 | $53 | |
11103 |
Biopsy of related skin growth, each additional growth | 195 | 109 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 170 | 136 | $98 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 145. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$920
Transactions
43
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $408.35 | |
| Janssen Biotech, Inc. | 7 | $219.32 | |
| Amgen Inc. | 5 | $120.77 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44.33 | |
| Incyte Corporation | 2 | $43.23 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $41.32 | |
| Dermavant Sciences, Inc. | 1 | $23.09 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $19.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,254
Patients
718
Total drug cost
$805,247
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 330 | 248 | $3,546 |
| Triamcinolone Acetonide | Generic | 193 | 140 | $3,256 |
| Doxycycline Hyclate | Generic | 145 | 109 | $3,240 |
| Otezla (Apremilast) | Brand | 127 | 11 | $444,576 |
| Ketoconazole | Generic | 120 | 65 | $2,612 |
| Fluticasone Propionate | Generic | 83 | 55 | $2,117 |
| Terbinafine Hcl | Generic | 44 | 21 | $657 |
| Spironolactone | Generic | 36 | 14 | $296 |
| Prednisone | Generic | 33 | 17 | $225 |
| Clindamycin Phosphate | Generic | 31 | 13 | $1,539 |
Hospital affiliations
Frequently asked questions
What is Dr. Myles Jerdan's medical specialty?
Dr. Myles Jerdan practices Dermatology Physician in Lagrange, GA.
Where does Dr. Myles Jerdan practice?
Dr. Myles Jerdan practices at 1605 Whitesville St, Lagrange, GA 302405903. Office phone: 8772313376.
What is Dr. Myles Jerdan's NPI?
Dr. Myles Jerdan's National Provider Identifier (NPI) is 1770549701, issued by NPPES.
Does Dr. Myles Jerdan accept Medicare assignment?
Yes. Dr. Myles Jerdan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Myles Jerdan commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Ultrasonic guidance for placement of radiation therapy fields (HCPCS G6001); Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS 77280). Source: CMS Medicare Physician & Other Practitioners file.